HQL

abrdn Life Sciences Investors

80 hedge funds and large institutions have $141M invested in abrdn Life Sciences Investors in 2025 Q3 according to their latest regulatory filings, with 14 funds opening new positions, 32 increasing their positions, 19 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed
Holders
80
Holders Change
Holders Change %
% of All Funds
Holding in Top 10
Holding in Top 10 Change
Holding in Top 10 Change %
% of All Funds
New
Increased
Reduced
Closed
Calls
Puts
Net Calls
Net Calls Change
Name Holding Trade Value Shares
Change
Change in
Stake
SCM
1
Saba Capital Management
New York
$40.1M
Morgan Stanley
2
Morgan Stanley
New York
$13.5M
PCM
3
Penserra Capital Management
California
$12.3M
Raymond James Financial
4
Raymond James Financial
Florida
$6.56M
NIM
5
Needham Investment Management
New York
$6.26M
LPL Financial
6
LPL Financial
California
$5.8M
FHA
7
Flagship Harbor Advisors
Massachusetts
$5.54M
RCM
8
Rivernorth Capital Management
Florida
$4.77M
KIM
9
Karpus Investment Management
New York
$4.66M
Allspring Global Investments
10
Allspring Global Investments
North Carolina
$3.65M
WAM
11
Wolverine Asset Management
Illinois
$3.34M
Ameriprise
12
Ameriprise
Minnesota
$3.25M
SFS
13
Shaker Financial Services
Virginia
$3.07M
AAM
14
Advisors Asset Management
Colorado
$2.47M
1WA
15
180 Wealth Advisors
Washington
$2.31M
1CP
16
1607 Capital Partners
Virginia
$1.89M
TJHA
17
Thomas J. Herzfeld Advisors
Florida
$1.81M
Bank of America
18
Bank of America
North Carolina
$1.75M
WIA
19
World Investment Advisors
California
$1.44M
Janney Montgomery Scott
20
Janney Montgomery Scott
Pennsylvania
$1.28M
Royal Bank of Canada
21
Royal Bank of Canada
Ontario, Canada
$1.23M
UPS
22
UHLMANN PRICE SECURITIES
Illinois
$1.15M
BBPWM
23
Blue Bell Private Wealth Management
Pennsylvania
$1.01M
PAG
24
Private Advisor Group
New Jersey
$988K
FAM
25
Formidable Asset Management
Ohio
$976K